[Head-up tilt test potentiated with nitroglycerin. What is the optimal duration of the test after administration of the drug?]

Rev Esp Cardiol. 2002 Jul;55(7):713-7. doi: 10.1016/s0300-8932(02)76689-x.
[Article in Spanish]

Abstract

Introduction and objectives: Numerous variations of the head-up tilt-table test potentiated with nitrates have been reported. After the administration of nitroglycerin, between 10 and 25 min of continued tilting have been recommended. The aim of this study was to assess the optimal duration of the pharmacological phase of the head-up tilt-table test potentiated with sublingual administration of nitroglycerin spray (NTG-TT).

Method: The records of 498 consecutive NTG-TT were reviewed. Our protocol consisted of a 20-min drug-free phase at a 60o angle. If syncope does not develop, 400 microgram of sublingual nitroglycerin spray is administered and the patient continues to be tilted for a further 25 min. The test results and time to a positive response were analyzed.

Results: The result of NTG-TT was positive in 288 procedures, most of them after nitroglycerin administration (255, 88.5%). The mean time to a positive response was 10.7 6.7 and 5.0 2.4 min during the control and pharmacological phases respectively. Most positive responses were concentrated in the 3 to 5 min after drug administration. The time to syncope after nitroglycerin administration was over 10 min in 9 patients and 15 min in only 2 patients.

Conclusions: The duration of the pharmacological phase of NTG-TT using the described protocol can be reduced to 15 min without loss of sensitivity. A further reduction to 10 min would decrease the rate of positive responses by a small amount and might be considered clinically acceptable.

Publication types

  • Comparative Study
  • Evaluation Study

MeSH terms

  • Administration, Sublingual
  • Electrocardiography
  • Heart Rate
  • Humans
  • Nitroglycerin* / administration & dosage
  • Syncope, Vasovagal / diagnosis*
  • Tilt-Table Test*
  • Time Factors

Substances

  • Nitroglycerin